PrestigeBio Pharmaceutical Celebrates Successful Completion of State-of-the-Art GMP Facility in South Korea

PrestigeBio Pharmaceuticals Co., Ltd. (PBK) has celebrated the successful completion of their first GMP facility located in Osong, South Korea at their official grand opening.

Over 200 attendees from not only Korea, but from all over the world came together to take part in the celebration.

Welcoming guests with a concert from the Italian Canzone led by the Grande Maestre, Professor Santo Oro, the event formally began with opening remarks from Michael Kim, CEO. Sharing in the festivities included distinguished guests, Lee Seo Chong, Govenor, Kim Jang Sung, Director of Korea Biotechnology Research Institute, and Park Gu Sun, Chairman of Kbio.

At this time also, vendors were acknowledged for their support and contribution to the development of Campus I. This milestone for PrestigeBio Pharmaceuticals brings the company closer to reaching their envisioned future of biopharmaceuticals — utilizing the most advanced antibody synthesis technologies to bring the highest quality antibody drugs at the most economical prices.

Since its construction beginning early of 2017, the new facility, Campus I, boasts cutting edge technology and a single-use production method increasing production efficiency. The campus spans across 10,560 m2 of land with a total production capacity of 6,000L. PBK has announced future plans to expand their first Osong Campus as well as begin constructing Campus II later next year to increase production yield up to 36,000L.

Read More